Voclosporin 7.9 MG Oral Capsule [Lupkynis] — RxCUI 2475406
RxNorm drug concept · Semantic branded drug
RxCUI 2475406
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2475406
Official nameVoclosporin 7.9 MG Oral Capsule [Lupkynis]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLupkynis 7.9 MG Oral Capsule
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)2,236 prescriptions · 21 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Voclosporin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Lupkynis (voclosporin) treats active lupus nephritis, which is kidney inflammation caused by lupus, in adults. It is always taken together with other immune-suppressing medicines....
- Swallow the capsule whole, twice a day, about 12 hours apart, on an empty stomach. Do not open or crush it. If you miss a dose, take it within 4 hours. Otherwise skip it, and never...
- Common ones are lower kidney filtering on blood tests, high blood pressure, diarrhea, headache, anemia, cough, and urinary tract infections. Your care team will watch your kidney f...
- Check with me or your doctor first. Strong CYP3A4 inhibitors such as ketoconazole, itraconazole and clarithromycin must not be used with it. Some others, like verapamil, diltiazem,...
🕸️ Concept Web — How Voclosporin 7.9 MG Oral Capsule [Lupkynis] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Voclosporin 7.9 MG Oral Capsule [Lupkynis]
RxCUI 2475406 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Voclosporin
2475166IN
-
Voclosporin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lupkynis
2475401BN
-
Lupkynis
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Voclosporin Oral Capsule
2475399SCDF -
Voclosporin Oral Product
2475397SCDG -
Voclosporin Pill
2475398SCDG -
Voclosporin Oral Capsule [Lupkynis]
2475403SBDF -
Lupkynis Oral Product
2475404SBDG -
Lupkynis Pill
2475405SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Voclosporin Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Voclosporin 7.9 MG Oral Capsule
2475400SCD -
Voclosporin 7.9 MG
2475396SCDC -
Voclosporin 7.9 MG [Lupkynis]
2475402SBDC
-
Voclosporin 7.9 MG Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Voclosporin 7.9 MG Oral Capsule
SCD · 2475400 -
Voclosporin 7.9 MG
SCDC · 2475396 -
Voclosporin Oral Capsule
SCDF · 2475399 -
Voclosporin Oral Product
SCDG · 2475397 -
Voclosporin Pill
SCDG · 2475398
Brand-Name Concepts
-
Voclosporin 7.9 MG [Lupkynis]
SBDC · 2475402 -
Voclosporin Oral Capsule [Lupkynis]
SBDF · 2475403 -
Lupkynis Oral Product
SBDG · 2475404 -
Lupkynis Pill
SBDG · 2475405 -
Lupkynis
BN · 2475401
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2475406 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 75626-0001-02 | 3 PACKET in 1 CARTON (75626-001-02) / 4 BLISTER PACK in 1 P... | LUPKYNIS | Aurinia Pharma U.S., Inc. | 2021-01-22 |
Observed labelers:
Aurinia Pharma U.S., Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.